Kim SH - Search Results

1

Neurotrophic activity of DA-9801, a mixture extract of Dioscorea japonica Thunb. and Dioscorea nipponica Makino, in vitro.

Kim N, Kim SH, Kim YJ, Kim JK, Nam MK, Rhim H, Yoon SK, Choi SZ, Son M, Kim SY, Kuh HJ. Kim N, et al. Among authors: kim yj, kim jk, kim sh, kim sy. J Ethnopharmacol. 2011 Sep 1;137(1):312-9. doi: 10.1016/j.jep.2011.05.032. Epub 2011 May 31. J Ethnopharmacol. 2011. PMID: 21651968

2

Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro.

Kim SH, Choi SJ, Kim YC, Kuh HJ. Kim SH, et al. Among authors: kim yc. Arch Pharm Res. 2009 Jun;32(6):915-22. doi: 10.1007/s12272-009-1614-2. Epub 2009 Jun 26. Arch Pharm Res. 2009. PMID: 19557370

3

Penetration of paclitaxel and 5-fluorouracil in multicellular layers of human colorectal cancer cells.

Choi MS, Kim SH, Kuh HJ. Choi MS, et al. Among authors: kim sh. Oncol Rep. 2011 Mar;25(3):863-70. doi: 10.3892/or.2011.1138. Epub 2011 Jan 10. Oncol Rep. 2011. PMID: 21225235

4

The reciprocal interaction: chemotherapy and tumor microenvironment.

Kim SH, Kuh HJ, Dass CR. Kim SH, et al. Curr Drug Discov Technol. 2011 Jun;8(2):102-6. doi: 10.2174/157016311795563875. Curr Drug Discov Technol. 2011. PMID: 21513484 Review.

5

Induction of caspase-2 activation by a DNA enzyme evokes tumor cell apoptosis.

Kim SH, Dass CR. Kim SH, et al. DNA Cell Biol. 2012 Jan;31(1):1-7. doi: 10.1089/dna.2011.1323. Epub 2011 Nov 11. DNA Cell Biol. 2012. PMID: 22077397 Review.

6

Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy.

Kim D, Goh HG, Kim SH, Cho BS, Kim DW. Kim D, et al. Among authors: kim dw, kim sh. Int J Hematol. 2011 Oct;94(4):361-371. doi: 10.1007/s12185-011-0921-9. Epub 2011 Sep 8. Int J Hematol. 2011. PMID: 21901399 Clinical Trial.

7

p53-targeted cancer pharmacotherapy: move towards small molecule compounds.

Kim SH, Dass CR. Kim SH, et al. J Pharm Pharmacol. 2011 May;63(5):603-10. doi: 10.1111/j.2042-7158.2010.01248.x. Epub 2011 Mar 31. J Pharm Pharmacol. 2011. PMID: 21492161 Review.

8

Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay.

Goh HG, Lin M, Fukushima T, Saglio G, Kim D, Choi SY, Kim SH, Lee J, Lee YS, Oh SM, Kim DW. Goh HG, et al. Among authors: kim dw, kim d, kim sh. Leuk Lymphoma. 2011 May;52(5):896-904. doi: 10.3109/10428194.2011.555569. Epub 2011 Feb 21. Leuk Lymphoma. 2011. PMID: 21338281

9

Analysis of Bcr-Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P-loop and T315I mutation is disease phase dependent.

Kim SH, Kim D, Kim DW, Goh HG, Jang SE, Lee J, Kim WS, Kweon IY, Park SH. Kim SH, et al. Among authors: kim dw, kim d, kim ws. Hematol Oncol. 2009 Dec;27(4):190-7. doi: 10.1002/hon.894. Hematol Oncol. 2009. PMID: 19274615

10

Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy.

Goh HG, Kim YJ, Kim DW, Kim HJ, Kim SH, Jang SE, Lee J, Kim D, Kim WS, Park SH, Kweon IY. Goh HG, et al. Among authors: kim yj, kim hj, kim dw, kim sh, kim d, kim ws. Leuk Lymphoma. 2009 Jun;50(6):944-51. doi: 10.1080/10428190902926973. Leuk Lymphoma. 2009. PMID: 19479613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,319 results

Search Page

Filters